Table 4.
Multivariate analysis of clinical factors associated with brain MRI T2 lesion burden
| B (unstandardized) | SE | β (standardized) | p-value | |
|---|---|---|---|---|
| Model 1: Fazekas scale as outcome | ||||
| Age in years | 0.051 | 0.019 | 0.304 | 0.011 |
| HCV antibody status | 1.015 | 0.346 | 0.339 | 0.005 |
| Current CD4+ cell count | −0.001 | 0.001 | −0.140 | 0.235 |
| African-American race (as compared to white) | 0.610 | 0.345 | 0.205 | 0.083 |
| Model 2: Scheltens scale as outcome | ||||
| Age in years | 0.327 | 0.124 | 0.320 | 0.011 |
| HCV antibody status | 4.489 | 7.096 | .243 | 0.050 |
| Current CD4+ cell count | −0.004 | 0.004 | −0.135 | 0.273 |
| African-American race (as compared to white) | 2.693 | 2.232 | 0.147 | 0.233 |
| Model 3: van Sweiten scale as outcome | ||||
| Age in years | 0.124 | 0.046 | 0.325 | 0.009 |
| HCV antibody status | 1.583 | 0.828 | 0.230 | 0.061 |
| Current CD4+ cell count | −0.002 | 0.001 | −0.180 | 0.143 |
| African-American race (as compared to white) | 1.115 | 0.826 | 0.163 | 0.183 |
HCV = hepatitis C virus; CD = cluster of differentiation; SE = standard error